Abstract Title:

Structural alterations of human immortal astrocytes after inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by lovastatin.

Abstract Source:

J Submicrosc Cytol Pathol. 1995 Oct ;27(4):435-44. PMID: 7585443

Abstract Author(s):

Y V Bobryshev, O V Pavlov, Y V Balabanov, K Ashwell

Article Affiliation:

Institute of the Human Brain, St Petersburg, Russia.

Abstract:

This investigation was designed to study the specific structural alterations of astroglial cells following the inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which is a key enzyme in cholesterol synthesis. In our previous investigations, it has been demonstrated that lovastatin, which is a specific competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, effectively inhibited cholesterol synthesis in human primary and immortal astrocytes in serum and lipid-free media, and we also showed that the effects on both astrocytes of primary cultures and immortal astrocytes (ASCh-7) were very similar. In the present study we therefore examined effects of lovastatin at a concentration of 100 ng/ml on human immortal astrocytes (ASCh-7) using electron microscopic analysis. We have found that lovastatin significantly affects human immortal astrocytes, resulting in degenerative ultrastructural changes including accumulation of a large number of phagosomes, oedema of the cytoplasm and destruction of gliofilaments. The results obtained suggest that the human immortal astrocyte cell line (ASCh-7) can be not only very useful for screening drugs in pharmacological research but can also provide a useful model for examining fine structural alterations of cells following selective disturbances of metabolism.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.